KELLY PAYNE: Open Payments
NPI 1972917755 · BRISTOL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,988 in 146 payments from 32 companies in 2025. Trend: 2023 $2,827 · 2024 $3,422 · 2025 $7,988
Speaker / faculty: $4,298Food & beverage: $3,015Consulting: $675
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $5,067 |
| ABBVIE INC. | 40 | $566 |
| UCB, Inc. | 13 | $421 |
| Alexion Pharmaceuticals, Inc. | 11 | $297 |
| Lundbeck LLC | 11 | $229 |
| TG Therapeutics, Inc. | 6 | $218 |
| GENZYME CORPORATION | 4 | $135 |
| MDD US Operations, LLC | 6 | $120 |
| Genentech USA, Inc. | 3 | $75 |
| Neurocrine BioSciences, Inc. | 3 | $72 |
Products named: NURTEC ODT, ULTOMIRIS, Briviact, UBRELVY, BRIUMVI, VYEPTI, BOTOX, QULIPTA.
Industry payments across TN — which companies pay providers there.
